This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583219 | PMC |
| http://dx.doi.org/10.1001/jamainternmed.2018.3031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis.
BMC Nephrol
October 2020
Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, WA, USA.
Background: Patients with end-stage kidney disease (ESKD) treated with hemodialysis (HD) experience many distressing symptoms. One frequently reported symptom is insomnia. There are unique issues about HD treatments and schedules that disrupt regular sleep/wake routines and possibly contribute to the high severity of insomnia.
View Article and Find Full Text PDFAssessment of Patterns of Potentially Unsafe Use of Zolpidem.
JAMA Intern Med
September 2018
Risk Sciences International, Ottawa, Ontario, Canada.
This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
View Article and Find Full Text PDFDrug Use on Mont Blanc: A Study Using Automated Urine Collection.
PLoS One
July 2017
Pôle Anesthésie-Réanimation, CHU de Grenoble, Grenoble, France.
Mont Blanc, the summit of Western Europe, is a popular but demanding high-altitude ascent. Drug use is thought to be widespread among climbers attempting this summit, not only to prevent altitude illnesses, but also to boost physical and/or psychological capacities. This practice may be unsafe in this remote alpine environment.
View Article and Find Full Text PDFHypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test.
Curr Drug Saf
January 2006
Utrecht Institute for Pharmaceutical Sciences, Department of Psychopharmacology, University of Utrecht, PO BOX 80082, 3508 TB, Utrecht, The Netherlands.
Background: Many people who use hypnotics are outpatients and are likely to drive a car the day after drug intake. The purpose of these meta-analyses was to determine whether or not this is safe.
Methods: Placebo-controlled, randomized, double-blind trials were selected if using the on-the-road driving test to determine driving ability the day following one or two nights of treatment administration.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!